Ancora Advisors, LLC Provectus Biopharmaceuticals, Inc. Transaction History

Ancora Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.04 - $0.18 $280 - $1,260	-7,000 Reduced 47.78%	7,650 $1,000
Q1 2022 May 13, 2022	SELL	$0.06 - $0.07 $7 - $8	-120 Reduced 0.81%	14,650 $1,000
Q3 2021 Nov 15, 2021	BUY	$0.06 - $0.07 $7 - $8	120 Added 0.82%	14,770 $1,000
Q1 2021 May 14, 2021	BUY	$0.06 - $0.08 $879 - $1,172	14,650 New	14,650 $1,000

229K

Ticker PVCT
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 419,496,992
Market Cap $37.8M
Description
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.